Prospects for gene therapy of insulin-dependent diabetes mellitus

Diabetologia

Volumn 41, Issue 12, 1998, Pages 1401-1409

  Efrat, S ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Beta cell lines; Conditional transformation; Gene transfer; Glucose regulated promoters; Immunomodulation; Insulin biosynthesis; Insulin secretion; Islet regeneration; Proinsulin processing; Transplantation

Indexed keywords

AUTOIMMUNITY; CELL DIFFERENTIATION; CELL TRANSPLANTATION; DIAGNOSTIC ACCURACY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SYNTHESIS; ONTOGENY; PRIORITY JOURNAL; PROMOTER REGION; REVIEW;

AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; HUMANS; INSULIN; ISLETS OF LANGERHANS; REGENERATION;

EID: 0031742518     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051085     Document Type: Review

References (88)

1. Crystal RG (1995) Transfer of genes to humans: early lessons and obstacles to success. Science 270: 404-410
2. Anderson WF (1998) Human gene therapy. Nature 392: 25-30
3. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986
4. Wicker LS, Todd JA, Peterson LB (1995) Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13: 179-200
5. Honeyman MC, Harrison LC, Drummond B, Colman PC, Tait BD (1995) Analysis of families at risk for IDDM reveals that HLA antigens influence progression to clinical disease. Mol Med 1: 576-582
6. Tisch R, McDevitt H (1996) Insulin-dependent diabetes mellitus. Cell 85: 291-297
7. Barnett AH, Eff C, Leslie RDG, Pyke DA (1981) Diabetes in identical twins: a study of 200 pairs. Diabetologia 20: 404-409
8. Gottlieb PA, Eisenbarth GS (1998) Diagnosis and treatment of pre-insulin dependent diabetes. Annu Rev Med 49: 391-405
9. Honeyman M, Wasserfal C, Nerup J, Rossini A (1997) Prediction and prevention of IDDM. Diabetologia 40[Suppl 3]: B58-B61
10. Iwahashi H, Hanafusa T, Eguchi Y et al. (1996) Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by bcl-2. Diabetologia 39: 530-536
11. Liu Y, Rabinovitch A, Suarez-Pinzon W et al. (1996) Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic ß cells from apoptosis. Human Gene Therapy 7: 1719-1726
12. Corbett JA, McDaniel ML (1992) Does nitric oxide mediate autoimmune destruction of β-cells? Diabetes 41: 897-903
13. Karlsen AE, Andersen HU, Vissing H et al. (1995) Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans. Diabetes 44: 753-758
14. Kubisch HM, Wang J, Luche R et al. (1994) Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes. Proc Natl Acad Sci USA 91: 9956-9959
15. Hohmeier HE, Thigpen A, Tran VV, Davis R, Newgard CB (1998) Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1 beta-induced cytotoxicity and reduces nitric oxide production. J Clin Invest 101: 1811-1820
16. Wold WSM, Gooding LR (1991) Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184: 1-8
17. Efrat S, Fejer G, Brownlee M, Horwitz MS (1995) Prolonged survival of murine pancreatic islet allografts mediated by adenovirus early region 3 immunoregulatory transgenes. Proc Natl Acad Sci USA 92: 6947-6951
18. von Herrath MG, Efrat S, Oldstone MBA, Horwitz MS (1997). Expression of adenoviral E3 transgenes in β cells prevents autoimmune diabetes. Proc Natl Acad Sci USA 94: 9808-9813
19. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H (1991) Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response. Cell 65: 319-331
20. Chervonsky AV, Wang Y, Wong FS et al. (1997) The role of Fas in autoimmune diabetes. Cell 89: 17-24
21. Kang SM, Schneider DB, Lin Z et al. (1997) Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Med 3: 738-743
22. Allison J, Georgiou HM, Strasser A, Vaux DL (1997) Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci USA 94: 3943-3947
23. Lau HT, Yu M, Fontana A, Stoeckert CJ (1996) Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273: 109-112
24. Lenschow DJ, Zeng Y, Thistlethwaite JR et al. (1992) Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257: 789-792
25. Weber CJ, Hagler MK, Chryssochoos JT et al. (1997) CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice. Cell Transplant 6: 505-508
26. Khoury SJ, Akalin E, Chandraker A et al. (1995) CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol 155: 4521-4524
27. McIntosh KR, Linsley PS, Drachman DB (1995) Immunosuppression and induction of anergy by CTLA4Ig in vitro: effects on cellular and antibody responses of lymphocytes from rats with experimental autoimmune myasthenia gravis. Cell Immunol 166: 103-112
28. Lenschow DJ, Ho SC, Sattar H et al. (1995) Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 181: 1145-1155
29. Mueller R, Krahl R, Sarvetnick N (1996) Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 184: 1093-1099
30. Balasa B, Sarvetnick N (1996) The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. J Autoimmun 9: 283-286
31. Corbett J, Serup P, Bonner-Weir S, Nielsen JH (1997) Beta-cell ontogeny: growth and death. Diabetologia 40: B27-B32
32. Dudek RW, Lawrence J, Hill RS, Johnson RC (1991) Induction of islet cytodifferentiation by fetal mesenchyme in adult pancreatic ductal epithelium. Diabetes 40: 1041-1048
33. Slack JMW (1995) Developmental Biology of the pancreas. Development 121: 1569-1580
34. Bouwens L, Kloppel G (1996) Islet cell neogenesis in the pancreas. Virchows Arch 427: 553-560
35. Madsen OD, Jensen J, Blume N et al. (1996) Pancreatic development and maturation of the islet B cell. Studies of pluripotent islet cultures. Eur J Biochem 242: 435-445
36. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE (1993) A second pathway for regeneration of adult exocrine and endocrine pancreas: a possible recapitulation of embryonic development. Diabetes 42: 1717-1720
37. Wang RN, Kloppel G, Bouwens L (1995) Duct-to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats. Diabetologia 38: 1405-1411
38. Gu D, Sarvetnick N (1993) Epithelial cell proliferation and islet neogenesis in IFN-g transgenic mice. Development 118: 33-46
39. Rooman I, Schuit F, Bouwens L (1997) Effects of vascular endothelial growth factor on growth and differentiation of pancreatic ductal epithelium. Lab Invest 76: 225-232
40. Rafaeloff R, Pittenger GL, Barlow SW et al. (1997) Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamster. J Clin Invest 99: 2100-2109
41. Lefebvre VH, Otonkoski T, Ustinov J et al. (1998) Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for β-cells. Diabetes 47: 134-137
42. Watanabe T, Yonemura Y, Yonekura H et al. (1994) Pancreatic beta-cell replication and amelioration of surgical diabetes by reg protein. Proc Natl Acad Sci USA 91: 3589-3592
43. Mashima H, Ohhishi H, Wakabayashi K et al. (1996) Beta-cellulin and activin A coordinately convert amylase-secreting pancreatic AR42 J cells into insulin-secreting cells. J Clin Invest 97: 1647-1654
44. Mashima H, Shibata H, Mine T, Kojima I (1996) Formation of insulin-producing cells from pancreatic acinar AR42 J cells by hepatocyte growth factor. Endocrinology 137: 3969-3976
45. Swenne I (1983) Effects of aging on the regenerative capacity of the pancreatic β-cell of the rat. Diabetes 32: 14-19
46. Hellerstrom C, Swenne I (1991) Functional maturation and proliferation of fetal pancreatic β-cells. Diabetes 40 [Suppl 2]: 89-93
47. Hayek A, Beattie GM, Cirulli V, Lopez AD, Ricordi C, Rubin JS (1995) Growth factor/matrix-induced proliferation of human adult β-cells. Diabetes 44: 1458-1460
48. Moore H-P, Walker MD, Lee F, Kelly RB (1983) Expressing a human insulin cDNA in a mouse ACTH-secreting cell: intracellular storage, proteolytic processing, and secretion on stimulation. Cell 35: 531-538
49. Vollenweider F, Irminger JC, Gross DJ, Villa-Komaroff L, Halban PA (1992) Processing of proinsulin by transfected hepatoma (FAO) cells. J Biol Chem 267: 14629-14636
50. Simpson AM, Tuch BE, Swan MA, Tu J, Marshall GM (1995) Functional expression of the human insulin gene in a human hepatoma cell line (HEP G2). Gene Therapy 2: 223-231
51. Lipes MA, Cooper EM, Skelly R et al. (1996) Insulin-secreting non-islet cells are resistant to autoimmune destruction. Proc Natl Acad Sci USA 93: 8595-8600
52. Valera A, Filial C, Costa C et al. (1994) Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations. FASEB J 8: 440-447
53. Kolodka TM, Finegold M, Moss L, Woo SL (1995) Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proc Natl Acad Sci USA 92: 3293-3297
54. Goldfine ID, German MS, Tseng HC et al. (1997) The endocrine secretion of human insulin and growth hormone by exocrine glands of the gastrointestinal tract. Nat Biotechnol 15: 1378-1382
55. Serup P, Jensen J, Andersen FG et al. (1996) Induction of insulin and IAPP production in pancreatic islet glucagonoma cells by insulin promoter factor 1. Proc Natl Acad Sci USA 93: 9015-9020
56. Groskreutz DJ, Sliwkowski MX, Gorman CM (1994) Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J Biol Chem 269: 6241-6245
57. Vollenweider F, Kaufmann J, Irminger JC, Halban PA (1995) Processing of proinsulin by furin, PC2, and PC3 in (co)transfected COS (monkey kidney) cells. Diabetes 44: 1075-1080
58. Kaufmann JE, Irminger J-C, Mungall J, Halban PA (1997) Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3. Diabetes 46: 978-982
59. Efrat S, Tal M, Lodish HF (1994) The pancreatic β-cell glucose sensor. Trends in Biochem Sci 19: 535-538
60. Hughes SD, Quaade C, Johnson JH, Ferber S, Newgard CB (1993) Transfection of AtT-20ins cells with GLUT2 but not GLUT1 confers glucose-stimulated insulin secretion: relationship to glucose metabolism. J Biol Chem 268: 15205-15212
61. Vaulont S, Kahn A (1994) Transcriptional control of metabolic regulation genes by carbohydrates. FASEB J 8: 28-35
62. Doiron B, Cuif MH, Kahn A, Diaz-Guerra MJ (1994) Respective roles of glucose, fructose, and insulin in the regulation of the liver-specific pyruvate kinase gene promoter. J Biol Chem 269: 10213-10216
63. Meyer S, Hoppner W, Seitz HJ (1991) Transcriptional and post-transcriptional effects of glucose on liver phosphoenolpyruvate-carboxykinase gene expression. Eur J Biochem 202: 985-991
64. Gros L, Montoliu L, Riu E, Lebrigand L, Bosch F (1998) Regulated production of mature insulin by non-beta-cells. Human Gene Therapy 8: 2249-2259
65. International Pancreas Transplantation Registry Newsletter (1995) 8[1]: 1-16
66. Sutherland DER (1996) Pancreas and islet transplantation: now and then. Transplant Proc 28: 2131-2133
67. International Islet Transplantation Registry Newsletter (1995) 5[1]:14
68. Lanza RP, Chick WL (1997) Transplantation of pancreatic islets. Annu NY Acad Sci 831: 321-331
69. Sullivan SJ, Maki T, Borland KM et al. (1991) Biohybrid artificial pancreas:long-term implantation studies in diabetic, pancreatectomized dogs. Science 252: 718-721
70. Lacy PE, Hegre OD, Gerasimidi-Vazeou A, Gentile FT, Dionne KE (1991) Maintenance of normoglycaemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 254: 1782-1784
71. Sun Y, Ma MX, Zhou D, Vacek I, Sun AM (1996) Normalization of diabetes in spontaneously diabetic cynomolgus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 98: 1417-1422
72. Bach FH, Fishman JA, Daniels N et al. (1998) Uncertainty in xenotransplantation: individual benefit versus collective risk. Nat Med 4: 141-144
73. Efrat S, Fusco-DeMane D, Lemberg H, Emran OA, Wang S (1995) Conditional transformation of a pancreatic β-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc Natl Acad Sci USA 92: 3576-3580
74. Santerre RF, Cook RA, Crisel RMD et al. (1981) Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells. Proc Natl Acad Sci USA 78: 4339-4342
75. Efrat S, Linde S, Kofod H et al. (1988) β-cell lines derived from transgenic mice expressing hybrid insulin-oncogenes. Proc Natl Acad Sci USA 85: 9037-9041
76. Miyazaki J-I, Araki K, Yamato E et al. (1990) Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127: 126-132
77. Hamaguchi K, Gaskins HR, Leiter EH (1991) NIT-1, a pancreatic β-cell line established from a transgenic NOD/Lt mouse. Diabetes 40: 842-849
78. Radvanyi F, Christgau S, Baekkeskov S, Jolicoeur C, Hanahan D (1993) Pancreatic β cells cultured from individual preneoplastic foci in a multistage tumorigenesis pathway: a potentially general technique for isolating physiologically representative cell lines. Mol Cell Biol 13: 4223-4232
79. Efrat S, Leiser M, Surana M et al. (1993) Murine insulinoma cell line with normal glucose-regulated insulin secretion. Diabetes 42: 901-907
80. Knaack D, Fiore DM, Surana M et al. (1994) Clonal insulinoma cell line which stably maintains correct glucose responsiveness. Diabetes 43: 1413-1417
81. Soldevila G, Buscema M, Marini V et al. (1991) Transfection with SV40 gene of human pancreatic endocrine cells. J Autoimmun 4: 381-396
82. Wang S, Beattie G, Mally M et al. (1997) Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. Cell Transplant 6: 59-67
83. Wang S, Beattie GM, Mally MI et al. (1997) Analysis of a human fetal pancreatic islet cell line. Transplant Proc 29: 2219
84. Levine F, Wang S, Beattie G et al. (1995) Development of a cell line from the human fetal pancreas. Transplant Proc 27: 3410
85. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547-5551
86. Ewald D, Li M, Efrat S et al. (1996) Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273: 1384-1386
87. Fleischer N, Chen C, Surana M et al. (1998) Functional analysis of a conditionally-transformed pancreatic β-cell line. Diabetes 47: 1419-1425
88. Sauer B, Henderson N (1989) Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome. Nucleic Acids Res 17: 147-161